Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo® Radiofrequency-Induced Thermochemotherapy Effect (RITE) With Mitomycin C (Synergo® RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC) Bacillus Calmette-Guérin (BCG)-Unresponsive Patients With or Without Papillary NMIBC

NCT03335059 is registered in ClinicalTrials.gov with Medical Enterprises Ltd. as lead sponsor.

NCT NCT03335059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03335059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo® Radiofrequency-Induced Thermochemotherapy Effect (RITE) With Mitomycin C (Synergo® RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC) Bacillus Calmette-Guérin (BCG)-Unresponsive Patients With or Without Papillary NMIBC
Lead sponsor
Medical Enterprises Ltd.
Phase
Phase 3
Overall status
Terminated
Start date
April 4, 2019
Completion date
February 26, 2020
Enrollment
5 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bcg-unresponsive bladder cancer, bladder cancer, bladder neoplasm, bladder tumors, cancer of bladder, cancer of the bladder, carcinoma in situ of bladder, malignant tumor of urinary bladder, neoplasms, bladder, papillary carcinoma of bladder (diagnosis), urinary bladder cancer